Compare

MOTS-c vs NAD+

Side-by-side observational reports from PeptIQ users. This compares self-reported patterns — not clinical head-to-head trials.

82 users report co-tracking this pair (47% of MOTS-c trackers also track NAD+).

Observational reporting only — not medical advice. Does not recommend doses, protocols, or treatments.
XRedditFacebook

MOTS-c

111 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 17% · Mixed 2% · Unfavorable overall 81%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Appetite
230
Energy
45
Mood
1
Recovery
1

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Injection site irritation
191

Self-reported dose per injection

Median bucket: 2–3 mg · Most common: 5+ mg

Reports span 0.01 to ≥ 5 mg (open-ended top bucket)

0.01–0.025 mg
4
0.1–0.2 mg
1
0.2–0.4 mg
8
0.4–0.6 mg
11
0.6–1 mg
8
1–2 mg
42
2–3 mg
44
3–5 mg
7
5+ mg
106

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 56% said they felt similar to their last entry, 31% more positive, and 13% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 44 days · Based on 45 repeat reporters

NAD+

96 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 2% · Mixed 98% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Energy
197
Appetite
197

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Headache
66
Nausea
64
Injection site irritation
64

Self-reported dose per injection

Median bucket: 5+ mg · Most common: 5+ mg

Reports span 0.1 to ≥ 5 mg (open-ended top bucket)

0.1–0.2 mg
2
0.2–0.4 mg
17
0.4–0.6 mg
8
0.6–1 mg
1
1–2 mg
2
3–5 mg
2
5+ mg
165

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 95% said they felt similar to their last entry, 5% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 51 days · Based on 42 repeat reporters

Explore other peptides